AK

Arda Kara

North America, California, United States, San Francisco

Description

Arda Kara

Investor Profile

Arda Kara has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (44%)
  • Series D (11%)
  • Convertible Note (11%)
  • Series B (11%)
  • Seed (11%)
  • Series Unknown (11%)

Country Focus

  • United States (78%)
  • Germany (11%)
  • Switzerland (11%)

Industry Focus

  • Health Care
  • Biotechnology
  • Software
  • Medical
  • Information Technology
  • Wellness
  • Neuroscience
  • Therapeutics
  • Biometrics
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arda Kara frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 3
Korify Capital
Europe, Sicilia, Italy, Santa Venerina
Co-Investments: 2
AirAngels
Europe, Wien, Austria, Vienna
Co-Investments: 1
Infinitas Capital
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 6
Labor Capital
North America, New York, United States, New York
Co-Investments: 2
Basement Fund
North America, New York, United States, New York
Co-Investments: 1
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 3
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 2

Which angels does Arda Kara often collaborate with?

BG
North America, Washington, United States, Seattle
Shared Deals: 1
MG
North America, New York, United States, New York
Shared Deals: 1
CS
Europe, Dublin, Ireland, Dublin
Shared Deals: 1
Shared Deals: 1
ML
North America, New York, United States, New York
Shared Deals: 1
AF
North America, United States
Shared Deals: 1
LR
North America, United States
Shared Deals: 1
MF
North America, Vermont, United States
Shared Deals: 1
David Rosenthal
North America, California, United States, San Francisco
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Arda Kara?

Levels

New York, New York, United States

Levels is a health and wellness company committed to improving metabolic health through biowearables.

BiometricsHealth CareInformation TechnologySoftwareWellness
Series AApr 20, 2022
Amount Raised: $38,000,000
Blackrock Neurotech

Salt Lake City, Utah, United States

Blackrock Neurotech is the platform for brain-computer interface (BCI) technology and manufacturing.

Machinery ManufacturingMedical DeviceNeuroscience
Convertible NoteNov 1, 2021
Human API

San Mateo, California, United States

Human API is a real-time health data network that gives consumers a simple way to view and share their health data from everywhere.

Developer APIsHealth CareReal TimeSoftware
Series UnknownNov 1, 2021
Akute Health

Austin, Texas, United States

Akute Health develops the medical record system for direct care & digital health companies

Health CareInformation TechnologyMedicalProductivity ToolsSoftware
SeedOct 30, 2021
Amount Raised: $455,000
Mindbloom

New York, New York, United States

Mindbloom helps to achieve personal and clinical breakthroughs with at-home, clinician-prescribed psychedelic therapies.

Health CareTherapeuticsWellness
Series BSep 1, 2021
Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series AMay 6, 2021
Amount Raised: $27,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series AMay 3, 2021
Amount Raised: $32,000,000
ATAI Life Sciences

Munich, Bayern, Germany

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyHealth CareLife ScienceMental HealthTherapeutics
Series DMar 3, 2021
Amount Raised: $157,000,000
Rejuveron Life Sciences

Schlieren, Zurich, Switzerland

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

BiotechnologyHealth CareMedical
Series ADec 1, 2020
Amount Raised: $25,012,061